Interview with Dr. Ben Sessa, Chief Medical Officer, Awakn Life Sciences

Awakn Life Sciences is a biotechnology company, researching, developing, and delivering psychedelic therapeutics to better treat addiction. Awakn’s team consists of world leading chemists, scientists, psychiatrists, and psychologists who are advancing the next generation of psychedelic drugs and therapies to be used in combination. Awakn will deliver these evidence backed psychedelic therapies in their clinics in the UK and Europe and through licensing partnerships globally.